Skip to content
Home
About Us
Our Products
Therapies
Media
Careers
Contact Us
Home
About Us
Our Products
Therapies
Media
Careers
Contact Us
Media
Blogs
Media Coverage
October 13, 2025
Lorem Ipsum 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo 2....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 3
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 4
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 5
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 8, 2025
Lorem Ipsum
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
Emcutix Launches SOLGLO-AZ Liposomal Serum For Hyperpigmentation
BW Health World
December 10, 2025
Read More
Emcutix Biopharmaceuticals Introduces SOLGLO-AZ Liposomal Serum: An Effective Answer to Hyperpigmentation for Indian Skin
PNI News
December 9, 2025
Read More
Emcutix Biopharma introduces SOLGLO-AZ liposomal serum for hyperpigmentation in India
Pharma Biz
December 9, 2025
Read More
Emcutix Biopharma unveils AquaOat with’s unique technological innovation
Pharmabiz
November 6, 2025
Read More
Emcutix Biopharmaceuticals launches AquaOat range for skin
India Med Today
November 6, 2025
Read More
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
Join the
Emcutix Circle
Be the first to hear about new launches, skin insights, and insider stories.